TomaszM.BeerMD

Oncology • Portland, OR

Genitourinary Oncology, Hematologic Oncology

Professor of Medicine at OHSU Knight Cancer Institute

Join to view full profile

Dr. Beer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Beer's full profile

Already have an account?

Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239
Phone+1 503-494-6594

Education & Training

Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 1996 - 1999
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1991 - 1996
Johns Hopkins University School of MedicineClass of 1991

Certifications & Licensure

OR State Medical License 1992 - 2025
WA State Medical License 1994 - 1996
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2007-2014
America's Top Doctors for Cancer Castle Connolly, 2006-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Portland Monthly Magazine Castle Connolly, 2011
Fellow (FACP) American College of Physicians, 2005
Join now to see all

Clinical Trials

Docetaxel in Treating Patients With Stage IV Prostate Cancer Start of enrollment: 1998 Dec 01
Completed
Phase 2
Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer Start of enrollment: 1999 Feb 01
Completed
Phase 2
Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer Start of enrollment: 2000 Sep 01
Completed
Phase 2
Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy Start of enrollment: 2000 Dec 01
Completed
Phase 2
Arsenic Trioxide in Treating Men With Germ Cell Cancer Start of enrollment: 2002 Apr 01
Completed
Phase 2
ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere Start of enrollment: 2002 Aug 01
Unknown status
Phase 2, Phase 3
S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED) Start of enrollment: 2004 Oct 01
Terminated
Phase 2
S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy Start of enrollment: 2003 Jul 01
Completed
Phase 2
SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel Start of enrollment: 2005 Apr 01
Completed
Phase 2
Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer Start of enrollment: 2002 Sep 01
Terminated
Not Applicable
Study of Aranesp to Treat Anemia in Prostate Cancer Patients. Start of enrollment: 2003 Apr 01
Completed
Phase 2
Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer Start of enrollment: 2007 Feb 01
Terminated
Phase 2
Docetaxel in Treating Patients With Relapsed Prostate Cancer Start of enrollment: 2007 May 01
Terminated
Phase 2
A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC) Start of enrollment: 2010 Mar 01
Terminated
Phase 3
Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel Start of enrollment: 2010 Jul 12
Terminated
Phase 2
Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer Start of enrollment: 2013 Jul 01
Terminated
Phase 1
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer Start of enrollment: 2014 Jan 23
Completed
Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical Practice Start of enrollment: 2019 Dec 12
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now.
Neal Shore, Sarah M Nielsen, Edward D Esplin, Emmanuel S Antonarakis, Pedro C Barata
JCO Oncology Practice. 2024-12-19
Comparative Transcriptomes of Canine and Human Prostate Cancers Identify Mediators of Castration Resistance.
Marcela Riveros Angel, Bernard Séguin, Christiane V Löhr, Tomasz M Beer, John Feliciano
Veterinary and Comparative Oncology. 2024-12-01
Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [Lu]Lu-PSMA...
Andrew J Armstrong, Oliver Sartor, Johann de Bono, Kim Chi, Karim Fizazi
European Urology. 2024-12-01

Journal Articles

Activity of Platinum-Based Chemotherapy in Patients with Advanced Prostate Cancer with and Without DNA Repair Gene Aberrations
Himisha Beltran, Che-Kai Tsao, Tomasz M Beer, JAMA Network Open
Development and Validation of a Prognostic Model for Overall Survival in Chemotherapy-Naïve Men with Metastatic Castration-Resistant Prostate Cancer
G Sonpavde, C S Higano, T M Beer, Annals of Oncology

Press Mentions

What a New Blood Test Could Mean for You — and for the Future of Cancer DetectionNovember 15th, 2024
Blood Tests That Detect Cancers Create Risks for Those Who Use ThemJune 10th, 2022
New Blood Test from Biotech Firm Planning to Hire 400 in RTP Can Detect 50+ Types of CancerJune 8th, 2021
Join now to see all

Grant Support

Resistance And Response Mechanisms To Prostate Cancer TherapyNational Cancer Institute2006–2009
Solid TumorsNational Cancer Institute2005–2009
A Novel Vitamin D Target In Human Prostate CancerNational Cancer Institute2006–2007
Acupuncture For HOT Flashes In Prostate Cancer PatientsNational Center For Research Resources2005
Transdermal Estrogen In Androgen-Independent Prostate CancerNational Center For Research Resources2004–2005
Acupuncture For HOT Flashes In Prostate Cancer PatientsNational Cancer Institute2003–2004
Oregon Prostate Cancer Conference 2001National Cancer Institute2001–2003
Pulse Calcitriol For Prostate Cancer PreventionNational Cancer Institute2000
Calcitriol In Recurrent Prostate CancerNational Cancer Institute2000